Table 3.
Reliability of new DSM-5 criteria: cannabis withdrawal and tobacco “abuse” criteria.
| Lifetime | Currenta | |||||
|---|---|---|---|---|---|---|
| % Test | % Retest | Kappa (95 % CI) | % Test | % Retest | Kappa (95 % CI) | |
| Cannabis withdrawal | ||||||
| Withdrawal criterion | 36.6 | 29.4c | 0.55 (0.48, 0.62) | 24.2 | 20.5c | 0.53 (0.44, 0.61) |
| Withdrawal syndromeb | 16.6 | 14.7 | 0.46 (0.36, 0.56) | 8.8 | 9.4 | 0.41 (0.29, 0.54) |
| 3+ withdrawal symptoms | 35.2 | 26.7c | 0.57 (0.50, 0.64) | - - | - - | - - |
| Used cannabis or another drug to relieve or avoid cannabis withdrawal symptoms | 31.7 | 25.0c | 0.55 (0.47, 0.62) | 21.6 | 17.5c | 0.51 (0.42, 0.60) |
| Individual lifetime cannabis withdrawal symptoms | ||||||
| Irritable, angry, or aggressive | 25.8 | 22.3c | 0.58 (0.51, 0.66) | - - | - - | - - |
| Lose weight, or have decreased appetite | 24.2 | 20.4c | 0.48 (0.39, 0.57) | - - | - - | - - |
| Feel nervous or anxious | 32.0 | 24.4c | 0.50 (0.42, 0.58) | - - | - - | - - |
| Feel restless, or like you couldn’t sit still | 29.0 | 21.6c | 0.51 (0.43, 0.59) | - - | - - | - - |
| Sleep disturbance | 40.4 | 29.9c | 0.49 (0.42, 0.56) | - - | - - | - - |
| Feel down or depressed | 30.8 | 23.4c | 0.50 (0.42, 0.58) | - - | - - | - - |
| Physical symptomsd | 25.1 | 20.2c | 0.56 (0.48, 0.64) | - - | - - | - - |
| Tobacco “abuse” criteria | ||||||
| Hazardous use | 38.4 | 37.2 | 0.73 (0.67, 0.78) | 28.7 | 26.7 | 0.67 (0.60, 0.74) |
| Social/Interpersonal problems | 11.0 | 9.4 | 0.37 (0.25, 0.49) | 8.3 | 7.1 | 0.34 (0.20, 0.48) |
| Neglect roles | 21.9 | 17.9c | 0.52 (0.43, 0.61) | 13.6 | 11.5 | 0.42(0.31, 0.53) |
CI = Confidence interval.
Interpretation of reliability coefficients: Fair: 0.21–0.40; moderate: 0.41–0.60; substantial: 0.61–0.80; excellent: 0.81–1.00.
Individual withdrawal symptoms were not assessed for the past-year time period, including those for cannabis withdrawal.
3+ withdrawal symptoms, clustering together in time, associated with self-acknowledged impairment.
Prevalence differed significantly between the test and retest interviews (McNemar’s test p < .05).
stomach pain, shaking hands, sweating, chills, headache, fever.